Hypera Stock

Hypera Operating Expenses

The Total Operating Expenses of Hypera (HYPE3.SA) as of Aug 16, 2026 is 207.96 M BRL. In the previous year, Total Operating Expenses was 234.81 M BRL — a change of -11.44% (lower).

Operating Expenses

207.96 MBRL

YoY

-11.44%

Last updated:

Total Operating Expenses of Hypera is 2026 207.96 M BRL. Total Operating Expenses of Hypera was 2025 234.81 M BRL. It decreases by -11.44% lower compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Total Operating Expenses of Hypera is 207.96 M BRL in 2026.

Total Operating Expenses of Hypera changed from 234.81 M BRL to 207.96 M BRL, representing a -11.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Hypera since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Hypera historically and in real time.

Access this data via the Eulerpool API

Income Statement — Hypera

All Key Metrics — Hypera